Determination of silodosin and its active glucuronide metabolite KMD‐3213G in human plasma by LC–MS/MS for a bioequivalence study

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-0801|32|2|bmc.4041-bmc.4041

ISSN： 0269-3879

Source： BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol.32, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

AbstractA sensitive and selective liquid chromatography–tandem mass spectrometry (LC–MS/MS) method is described for the simultaneous determination of silodosin (SLD) and its active metabolite silodosin β‐d‐glucuronide (KMD‐3213G) in human plasma. Liquid–liquid extraction of plasma samples was carried out with ethyl acetate and methyl tert‐butyl ether solvent mixture using deuterated analogs as internal standards. The extraction recoveries of SLD and KMD‐3213G were in the ranges 90.8–93.4 and 87.6–89.9%, respectively. The extracts were analyzed on a Symmetry C18 (50 × 4.6 mm, 5 μm) column under gradient conditions using 10 mm ammonium formate in water and methanol–acetonitrile (40:60, v/v), within 6.0 min. For MS/MS measurements, ionization of the analytes was carried out in the positive ionization mode and the transitions monitored were m/z 496.1 → 261.2 for SLD and m/z 670.2 → 494.1 for KMD‐3213G. The method showed good linearity, accuracy, precision and stability in the range 0.10–80.0 ng/mL for SLD and KMD‐3213G. The IS‐normalized matrix factors obtained were highly consistent, ranging from 0.962 to 1.023 for both analytes. The method was used to support a bioequivalence study of SLD and its metabolite in healthy volunteers after oral administration of 8 mg silodosin capsules.

Related content

A sensitive LC–MS/MS method for simultaneous quantification of geniposide and its active metabolite genipin in rat plasma and its application to a pharmacokinetic study

By  

BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol. 32, Iss. 3, 2018-03 ,pp. : n/a-n/a (NaN)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reliable LC‐MS/MS assay for the estimation of rilpivirine in human plasma: application to a bioequivalence study and incurred sample reanalysis

By  

DRUG TESTING AND ANALYSIS, Vol. 7, Iss. 4, 2015-04 ,pp. : 290-299 (10)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simultaneous determination of caffeic acid and its major pharmacologically active metabolites in rat plasma by LC‐MS/MS and its application in pharmacokinetic study

By  

BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol. 29, Iss. 4, 2015-04 ,pp. : 552-559 (8)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determination of tigecycline in human plasma by LC–MS/MS and its application to population pharmacokinetics study in Chinese patients with hospital‐acquired pneumonia

By  

BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a (NaN)

John Wiley & Sons Inc

Access to resources Recommend Favorite

A rapid and sensitive determination of hypoxic radiosensitizer agent nimorazole in rat plasma by LC‐MS/MS and its application to a pharmacokinetic study

By  

BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol. 29, Iss. 10, 2015-10 ,pp. : 1575-1580 (6)

John Wiley & Sons Inc

Access to resources Recommend Favorite